First Trust Advisors LP Sells 175,201 Shares of Healthpeak Properties, Inc. $DOC

Key Points

• First Trust Advisors LP trimmed its stake in Healthpeak Properties by 7.4% in Q3, selling 175,201 shares and leaving it with 2,187,838 shares (about 0.31% of the company) valued at roughly $41.9 million; institutional investors now own ~93.6% of the stock.
• Healthpeak declared a monthly dividend of $0.1017 (ex-dividend Mar 17, payable Mar 31), implying a 7.2% yield
• The REIT beat quarterly estimates with $0.47 EPS and $719.4M revenue, set FY2026 guidance of $1.70–1.74 EPS, and sits at a consensus analyst rating of "Hold" with a $19.42 price target.

First Trust Advisors LP lowered its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 7.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,187,838 shares of the real estate investment trust's stock after selling 175,201 shares during the quarter. First Trust Advisors LP owned approximately 0.31% of Healthpeak Properties worth $41,897,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of DOC. Integrated Wealth Concepts LLC boosted its stake in shares of Healthpeak Properties by 7.3% in the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust's stock valued at $366,000 after purchasing an additional 1,231 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Healthpeak Properties by 110.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust's stock worth $2,463,000 after purchasing an additional 63,930 shares during the period. Woodline Partners LP raised its position in Healthpeak Properties by 41.3% in the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust's stock worth $1,195,000 after purchasing an additional 17,279 shares during the period. ProShare Advisors LLC lifted its stake in Healthpeak Properties by 18.1% in the second quarter. ProShare Advisors LLC now owns 214,591 shares of the real estate investment trust's stock worth $3,757,000 after purchasing an additional 32,883 shares during the last quarter. Finally, Allworth Financial LP lifted its stake in Healthpeak Properties by 1,350.8% in the second quarter. Allworth Financial LP now owns 69,842 shares of the real estate investment trust's stock worth $1,223,000 after purchasing an additional 65,028 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $16.88 on Friday. The firm has a market capitalization of $11.74 billion, a price-to-earnings ratio of 168.86, a PEG ratio of 9.14 and a beta of 1.12. The stock has a fifty day moving average of $17.17 and a 200 day moving average of $17.57. Healthpeak Properties, Inc. has a 52 week low of $15.71 and a 52 week high of $20.81. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The business had revenue of $719.40 million for the quarter, compared to the consensus estimate of $685.14 million. During the same period in the previous year, the firm earned $0.46 EPS. The company's quarterly revenue was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, research analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) annualized dividend and a dividend yield of 7.2%. Healthpeak Properties's payout ratio is currently 1,220.00%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Cantor Fitzgerald set a $17.00 price objective on Healthpeak Properties in a research note on Monday, January 5th. Evercore lowered their target price on Healthpeak Properties from $21.00 to $19.00 and set an "outperform" rating for the company in a research note on Wednesday, February 4th. The Goldman Sachs Group began coverage on Healthpeak Properties in a report on Friday, January 9th. They set a "neutral" rating and a $17.00 target price for the company. Argus lowered Healthpeak Properties from a "buy" rating to a "hold" rating in a research report on Thursday, February 5th. Finally, Wells Fargo & Company reaffirmed a "positive" rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $19.42.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.